Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Embrace the Outside: Exercises and Entertainment - 2How mountain terraces have helped Indigenous peoples live with climate uncertainty
- 3A quick recap of 'Stranger Things' Seasons 1-4, plus key episodes to rewatch before Volume 1 of the final season drops
- 4Investigating the Advantages of a Bank account: A Complete Aide
- 5Sa'ar warns German delegation: 'A Palestinian state would be a Hamas terror state'
- My Enterprising Excursion: Building a Startup
- Vote in favor of your Number one method for commending a birthday
- Manual for 6 famous sorts of cheddar
- Far-right German youth group delegates seek deportations, remigration
- What to know as New York City nurses strike for a 3rd day
- The Benefits of Rehearsing Careful Nurturing
- Current Chateaus: Advancement and Style
- Brazil judge orders government to add JBS subsidiary to 'dirty list' for slavery
- Popular Home Rug Series For You
